| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/16/2011 | EP2295053A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses |
| 03/16/2011 | EP2294058A1 2-(benzylsulfonyl)-oxazole derivatives, chiral 2- (benzylsulfinyl) -oxazole derivatives and 2-(benzylsulfanyl)-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators |
| 03/16/2011 | EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them |
| 03/16/2011 | EP2155683B1 Pyridone derivatives as p38a mapk inhibitors |
| 03/16/2011 | EP2046758B1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/16/2011 | EP1991542B1 Herbicidal isoxazoline compounds |
| 03/16/2011 | EP1703906B1 Immuno inhibitory pyrazolone compounds |
| 03/16/2011 | EP1417186B1 Heterocyclic aryl sulphonamides |
| 03/16/2011 | CN101260075B Aralkylpiperidine derivative and application thereof in preparing analgesic and sedative medicament |
| 03/15/2011 | US7906655 5,5'-(1,2-ethynediyl)bis(2-((2S)-1-((2R)-2-phenylpropanoyl)-2-pyrrolidinyl)-1H-benzimidazole); inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906546 Tetrahydrocarbazoles and derivatives |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906510 Amide derivative and pharmaceutical composition containing the same |
| 03/15/2011 | US7906509 Inhibitors of bruton's tyrosine kinase |
| 03/15/2011 | US7906508 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity |
| 03/15/2011 | US7906505 Apoptosis promoters |
| 03/15/2011 | US7906502 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/15/2011 | CA2550596C 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 03/15/2011 | CA2432000C Pyrimidineamines as angiogenesis modulators |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/10/2011 | WO2011028860A2 Compounds and compositions for treating cancer |
| 03/10/2011 | WO2011028741A1 Quinazolines as potassium ion channel inhibitors |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2011027289A1 Chromone derivatives, a process for their preparation and their therapeutic applications |
| 03/10/2011 | WO2011027249A2 Benzimidazole derivatives |
| 03/10/2011 | WO2011026917A1 Heteroaryl compounds as kinase inhibitors |
| 03/10/2011 | WO2011026911A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026890A1 2, 3, 6 -triamino substituted pyridines as kv7 (kcnq) channel modulators |
| 03/10/2011 | WO2011026579A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | WO2011026241A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | US20110060011 Oxazole compounds compositions and methods of use |
| 03/10/2011 | US20110059988 Isoxazoline compositions and their use as antiparasitics |
| 03/10/2011 | US20110059979 Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059969 Piperazines as anti-obesity agents |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059967 Therapeutic compounds |
| 03/10/2011 | US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059962 Transcription factor modulating compounds and methods of use thereof |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059958 Morpholinone compounds as factor ixa inhibitors |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059948 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
| 03/10/2011 | US20110059946 Dual action antibiotics |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059934 Compounds and compositions useful for the treatment of parasitic diseases |
| 03/10/2011 | US20110059893 Compounds for the treatment of proliferative disorders |
| 03/10/2011 | US20110059161 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | US20110059043 Chemical compounds |
| 03/10/2011 | US20110059018 Covalently binding imaging probes |
| 03/10/2011 | CA2772790A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | CA2772642A1 Quinazolines as potassium ion channel inhibitors |
| 03/10/2011 | CA2772614A1 Compounds and compositions for treating cancer |
| 03/10/2011 | CA2772194A1 Benzimidazole derivatives |
| 03/10/2011 | CA2771592A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | CA2771568A1 Heteroaryl compounds as kinase inhibitors |
| 03/10/2011 | CA2771563A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | CA2771061A1 Chromone derivatives, a process for their preparation and their therapeutic applications |
| 03/09/2011 | EP2292616A1 Novel polymorphic form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 03/09/2011 | EP2292608A1 Intermediates for the preparation of substituted Aminosalicylic acid amides with fungicidal activity |
| 03/09/2011 | EP2292601A1 Phenanthro[2,3-b]pyrroles and Phenanthro[3,2-b]pyrroles for organic light-emitting devices |
| 03/09/2011 | EP2291373A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/09/2011 | EP2291371A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/09/2011 | EP2291370A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/09/2011 | EP2291365A1 5-substituted isoindoline compounds |
| 03/09/2011 | EP2291359A1 Phenyl or pyridinyl substituted indazoles derivatives |
| 03/09/2011 | EP2291080A1 Novel modulators of sphingosine phosphate receptors |
| 03/09/2011 | EP2201006B1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 03/09/2011 | EP2144904B1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent |
| 03/09/2011 | EP2077998B1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/09/2011 | EP1732920B1 Thiophene derivatives as chk 1 inhibitors |
| 03/09/2011 | EP1692116B1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | EP1513812B1 Substituted indoles |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101326167B Pyridiazinone derivatives for tumour treatment |
| 03/08/2011 | US7902379 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902356 Thiazolopyridinone derivates as MCH receptor antagonists |
| 03/08/2011 | US7902239 Diaminotriazoles useful as inhibitors of protein kinases |
| 03/08/2011 | US7902231 Anthropodicidal anthranilamides |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7902191 Histamine H3 receptor antagonists, preparation and therapeutic uses |
| 03/08/2011 | US7902189 Compounds |
| 03/08/2011 | US7902188 Morpholine dopamine agonists |
| 03/08/2011 | US7902181 Compounds 010 |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/03/2011 | WO2011025965A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | WO2011025706A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 03/03/2011 | WO2011025565A1 Morpholinone compounds as factor ixa inhibitors |